Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13)
NANot yet recruitingINTERVENTIONAL
Enrollment
650
Participants
Timeline
Start Date
September 1, 2025
Primary Completion Date
March 1, 2027
Study Completion Date
March 1, 2027
Conditions
Genetic Disease
Interventions
DIAGNOSTIC_TEST
SHANK3 mutation
blood sampling for diagnostic test
Trial Locations (1)
75019
Robert Debré Hospital, Paris
All Listed Sponsors
lead
Assistance Publique - Hôpitaux de Paris
OTHER
NCT07119606 - Multicenter Study of Patients With SHANK3 Mutations: Identification of Genes Modificators in Phelan-McDermid Syndrome (EUQ13) | Biotech Hunter | Biotech Hunter